
Eurazeo holds €500m final close for Eurazeo Capital II
Listed buyout house Eurazeo has held a final close on €500m for its second co-investment vehicle Eurazeo Capital II.
Launched in early June 2016, the GP's fundraising activity was paused for nearly a month in the aftermath of the UK's referendum on EU membership, according to a source. Nevertheless, the fund is understood to have reaped allocation requests in excess of its €500m target.
With a minimum lifespan of nine years, the vehicle targets growth capital injections across the GP's portfolio. Managed by the Eurazeo's team in Luxembourg, the fund will purchase a 25% stake in several of the GP's portfolio companies with the aim to support their international expansion. Moreover, the fund manager is understood to operate a 7.5% hurdle rate and 20% carried interest.
In a statement, Eurazeo claimed the launch of the new vehicle will bring its volume of assets under management to €6bn, of which €1bn is managed for third parties.
Investors
According to a statement, the fund raised committed capital from international pension funds, asset management firms, sovereign wealth funds and family offices. The majority (73%) of subscribing LPs are based in Europe, while 15% of the remaining LPs are located in North America and 12% in Asia.
Investments
The fund will acquire a 25% minority stake across seven of Eurazeo's non-listed portfolio companies: Asmodée, Desigual, Neovia, Fintrax Group, Les Petits Chaperons Rouges, Novacap and Sommet Education, for an aggregate €340m injection.
Moreover, the GP aims to allocate the remaining €160m to a newco, CPK, which will be created in the first half of 2017 with the purpose of acquiring three new businesses – Carambar, Poulain and Krema – from US-listed corporate Mondelez International, as well as for add-on investments for its current portfolio companies.
People
Eurazeo Capital – Marc Frappier (managing director).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater